On August 16, 2023, Citizens Jmp began coverage of Assembly Biosciences (NASDAQ: ASMB), assigning an “outperform” rating along with a target price of $38.00. This biopharmaceutical...
Investors are closely examining the performance of two prominent medical companies, LivaNova (NASDAQ: LIVN) and Hologic (NASDAQ: HOLX), as they assess which firm holds a stronger...
Sotera Health Company (NASDAQ: SHC) has received a consensus recommendation of “Moderate Buy” from five research firms currently tracking the stock, according to a report from...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received a consensus rating of “Buy” from the five brokerage firms currently covering its stock, according to a report by Marketbeat...
Investors are weighing the merits of two prominent technology firms, Fortinet (NASDAQ: FTNT) and Varonis Systems (NASDAQ: VRNS), as potential additions to their portfolios. This analysis...
Major shareholder Jan Stahlberg has significantly increased his investment in DiaMedica Therapeutics, Inc. (NASDAQ: DMAC) by acquiring 59,788 shares on August 22, 2023. The shares were...
Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
The utility sector is experiencing a remarkable transformation in 2025, emerging as a surprising leader in the stock market. Traditionally viewed as a defensive investment, utilities...
Royce & Associates LP has taken a significant step by investing approximately $4.19 million in Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) during the first quarter of 2023....
Tesla (NASDAQ: TSLA) has announced its earnings results for the second quarter of 2025. Released on July 23, 2025, after market hours, the update letter provides...
